Old Web
English
Sign In
Acemap
>
authorDetail
>
T. Robak
T. Robak
Medical University of Łódź
Internal medicine
Oncology
Medicine
Chronic lymphocytic leukemia
relapsed refractory
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2
2021
Hematological Oncology
Steven Coutre
Paul M. Barr
Carolyn Owen
T. Robak
Alessandra Tedeschi
Osnat Bairey
Jan A. Burger
Peter Hillmen
S Devereux
Sebastian Grosicki
Helen McCarthy
Jian-yong Li
D. Simpson
Fritz Offner
Carol Moreno
S. Dai
A. Szöke
J. P. Dean
Thomas J. Kipps
Paolo Ghia
Show All
Source
Cite
Save
Citations (0)
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY
2021
Hematological Oncology
Min Wang
Simon Rule
P. L. Zinzani
Andre Goy
O. Casasnovas
Stephen D. Smith
Ghandi Damaj
J. K. Doorduijn
T. Lamy
F. Morschhauser
Carlos Panizo
Bhavana Shah
Andrew Davies
Richard Eek
Jehan Dupuis
Eric N. Jacobsen
Arnon P. Kater
S. Le Gouill
Lucie Oberic
T. Robak
P. Jain
Roser Calvo
Lin Tao
Monika Długosz-Danecka
Show All
Source
Cite
Save
Citations (0)
Five-Year Analysis of Murano Study Demonstrates Enduring Undetectable Minimal Residual Disease (uMRD) in a Subset of Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Patients (Pts) Following Fixed-Duration Venetoclax-Rituximab (VenR) Therapy (Tx)
2020
Blood
Arnon P. Kater
Thomas J. Kipps
Barbara Eichhorst
Peter Hillmen
James DRozario
Carolyn Owen
Sarit Assouline
Nicole Lamanna
T. Robak
Javier de la Serna
Ulrich Jaeger
Guillaume Cartron
Marco Montillo
Clemens Mellink
Brenda Chyla
Cameron Wilson
Jenny Wu
Yanwen Jiang
Marcus Lefebure
Michelle Boyer
John F. Seymour
Show All
Source
Cite
Save
Citations (19)
1